{"id":"W4362588616","doi":"10.1016/s1556-0864(23)00335-0","title":"81TiP NVL-655, a selective anaplastic lymphoma kinase (ALK) inhibitor, in patients with advanced ALK-positive solid tumors: The phase I/II ALKOVE-1 study","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb","keywords":"Anaplastic lymphoma kinase; Medicine; ALK inhibitor; Crizotinib; Cancer research; Lung cancer; Metastasis; Cancer; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009135185,0.001080188,0.001158369,0.0002668206,0.0001982867,0.0008966373,0.0005645485,0.0007027783,0.001853883],"category_scores_gemma":[0.0004628918,0.0003708779,0.001183743,0.0003224344,0.0004339348,0.0006652631,0.0002612728,0.00201086,0.0005651138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007124433,"about_ca_system_score_gemma":0.0007704635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009513574,"about_ca_topic_score_gemma":0.003663353,"domain_scores_codex":[0.9997535,0.00009705848,0.00001292062,0.00004365134,0.00002880707,0.00006406064],"domain_scores_gemma":[0.9997451,0.0000423024,0.00004848135,0.00001584018,0.00001928409,0.0001289884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5034154,0.02623642,0.03207719,0.002106918,0.005948893,0.0003661707,0.0002866882,0.005908083,0.06311155,0.0007601957,0.01417506,0.3456075],"study_design_scores_gemma":[0.5563504,0.338424,0.07803813,0.0001962114,0.003856693,0.0007593934,0.0002178933,0.003734375,0.006364093,0.0007841521,0.01117834,0.00009650402],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871656,0.007295264,0.0003649579,0.0005592097,0.00015075,0.0003892524,0.001159097,0.0000873528,0.002828461],"genre_scores_gemma":[0.9867883,0.005123116,0.0009006697,0.001186606,0.0001543192,0.0003875626,0.002744125,0.00002720282,0.002688133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001853883,"threshold_uncertainty_score":0.006201863,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01031932732610439,"score_gpt":0.4090416303925772,"score_spread":0.3987223030664728,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}